CISATRACURIUM BESYLATE and ANAPHYLACTIC SHOCK

Overview

ANAPHYLACTIC SHOCK is the #3 most commonly reported adverse reaction for CISATRACURIUM BESYLATE, manufactured by Fresenius Kabi USA, LLC. There are 116 FDA adverse event reports linking CISATRACURIUM BESYLATE to ANAPHYLACTIC SHOCK. This represents approximately 3.2% of all 3,661 adverse event reports for this drug.

Patients taking CISATRACURIUM BESYLATE who experience anaphylactic shock should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ANAPHYLACTIC SHOCK is moderately reported among CISATRACURIUM BESYLATE users, representing a notable but not dominant share of adverse events.

Other Side Effects of CISATRACURIUM BESYLATE

In addition to anaphylactic shock, the following adverse reactions have been reported for CISATRACURIUM BESYLATE:

• OFF LABEL USE — 156 reports
• HYPOTENSION — 146 reports
• ANAESTHETIC COMPLICATION NEUROLOGICAL — 115 reports
• DRUG INEFFECTIVE — 113 reports
• DRUG INTERACTION — 113 reports
• ANAPHYLACTIC REACTION — 112 reports
• RHABDOMYOLYSIS — 83 reports
• CARDIAC ARREST — 82 reports
• ACUTE KIDNEY INJURY — 74 reports
• DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS — 72 reports

Other Drugs Associated with ANAPHYLACTIC SHOCK

The following drugs have also been linked to anaphylactic shock in FDA adverse event reports:

Does CISATRACURIUM BESYLATE cause ANAPHYLACTIC SHOCK?

ANAPHYLACTIC SHOCK has been reported as an adverse event in 116 FDA reports for CISATRACURIUM BESYLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ANAPHYLACTIC SHOCK with CISATRACURIUM BESYLATE?

ANAPHYLACTIC SHOCK accounts for approximately 3.2% of all adverse event reports for CISATRACURIUM BESYLATE, making it one of the most commonly reported side effect.

What should I do if I experience ANAPHYLACTIC SHOCK while taking CISATRACURIUM BESYLATE?

If you experience anaphylactic shock while taking CISATRACURIUM BESYLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages